FindTrial
Sign In

Part 2

BEHAVIORAL5 trials

Sponsors

University of Minnesota, Memorial Sloan Kettering Cancer Center, Daewoong Pharmaceutical Co. LTD., Sun Pharma Advanced Research Company Limited, Harmony Biosciences Management, Inc.

Conditions

Advanced Breast CancerAdvanced Gastrointestinal CancerContinued SmokingDrug InteractionHER2-negative Breast CancerHRTHormone Receptor-positive Breast CancerMild to Moderate COVID-19

Phase 1

A Study in Patients With Advanced Breast Cancer
TerminatedNCT04942054
Sun Pharma Advanced Research Company LimitedAdvanced Breast Cancer, HER2-negative Breast Cancer, Hormone Receptor-positive Breast Cancer
Start: 2022-05-20End: 2023-02-28Updated: 2023-05-22
Drug Interaction Study of ZYN002 Transdermal Gel and Probe Substrates
CompletedNCT06930872
Harmony Biosciences Management, Inc.Drug Interaction
Start: 2025-06-06End: 2025-11-04Updated: 2026-02-09

Phase 2

Efficacy and Safety of DWJ1248 in Patients With Mild to Moderate COVID-19 Compared to the Placebo
TerminatedNCT04521296
Daewoong Pharmaceutical Co. LTD.Mild to Moderate COVID-19
Start: 2020-09-11End: 2022-03-18Updated: 2022-06-15

Unknown Phase

Tobacco Cessation in Postmenopausal Women
CompletedNCT01210586
University of MinnesotaContinued Smoking, HRT, Non-HRT +1
Start: 1999-01-31End: 2008-01-31Updated: 2020-06-26
Person-Centered Oncology Care and Choices (P-COCC): Piloting and Initial Randomized Testing of a Combined Values Narrative Interview and Video Education Advance Care Planning Program in Gastrointestinal Oncology Patients
CompletedNCT01912131
Memorial Sloan Kettering Cancer CenterAdvanced Gastrointestinal Cancer
Start: 2013-07-31End: 2020-01-31Updated: 2020-01-22

Related Papers

A Double-Blind, Randomized, Placebo-Controlled, Phase II Clinical Study To Evaluate the Efficacy and Safety of Camostat Mesylate (DWJ1248) in Adult Patients with Mild to Moderate COVID-19.
2022-12-1418 citations
Qualitative study of cancer patients’ advance care planning (ACP) values.
Journal of Clinical Oncology2018-05-20
Acceptability and effects of values-based outpatient advance care planning (ACP) in gastrointestinal (GI) cancers.
Journal of Clinical Oncology2017-11-011 citations
Acceptability and effects of values-based outpatient advanced care planning (ACP) in gastrointestinal (GI) cancers.
Journal of Clinical Oncology2017-05-20